Application of UV-Spectrophotometry and HPLC for determination of Venlafaxine and its four related substances in pharmaceutical dosage forms;Venlafaksin ve ilgili Dört Maddenin Farmasötik Dozaj Formlannda Miktar Tayini için UV Spektrofotometri ve YPSK'nın Uygulanması

Turkish Journal of Pharmaceutical Sciences

Volumn 8, Issue 2, 2011, Pages 91-104

  Hosseini, Maryam ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Liquid chromatography; Pharmaceutics; Related substances; Spectrophotometry; Venlafaxine

Indexed keywords

ACETONITRILE; BUFFER; METHANOL; PHOSPHATE; VENLAFAXINE;

ACCURACY; ARTICLE; CHEMICAL COMPOSITION; CHROMATOGRAPHY; CONTROLLED STUDY; DISSOLUTION; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG IMPURITY; DRUG STRUCTURE; ELUTION; FLOW RATE; LIMIT OF QUANTITATION; MOBILE PHASE; PH; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLVENT EFFECT; TABLET; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 79960090381     PISSN: 1304530X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ferrier, I.N., "Treatment of major depression" Clin Psychiatry, 6, 4-10, 1999.
2. We, L., Feng, W., Huan-de, L., "Simultaneos stereoselective analysis of Venlafaxine and O-desmethyl venlafaxine enantiomers in human plasma by HPLC-ESI/MS using a vancomycin chiral column" J. Chromatogr. B, 850, 183-189, 2007.
3. Asafu-Adjaya, E., Faustino, P., Tawakkul, M., W. Anderson, L. Yu., "Validation and application of a stability-indicating HPLC method for in vitro determination of gastric and intestinal stability of venlafaxine" Pharm. Biomed. Anal., 43, 1854-1859, 2007.
4. Rao, N., Narasa Raju, A., "Simultaneous separation and determination of process related substances and degradation products of venlafaxine by reversed-phase HPLC" Separation Science, 29, 2733-2744, 2006.
5. Dalletm, P., Labat, M., Richard, M., Langlois, H., Dubost, P., "A reversed phase HPLC method development for the separation of new antidepressants" J. Liq. Chromatogr. Rel. Technol., 25, 101-111, 2002.
6. Charlote, D., Grandmaison, de la., Lorin, G., Mazancourt, D. jean-Claude, A., "A High-Performance Liquid Chromatography Method with photodiode array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs" Therapeutic Drug Monitoring, 25, 565-573, 2003.
7. Wei, Z., Bing-ren, X., Cai-yun, W., "Liquid chromatography-mass spectroscopy method for the determination of venlafaxine in human plasma and application to a pharmacokinetic study" Biomed. Chromatogr., 21, 266-272, 2007.
8. Yang, X., Jin, M., Zhou, J., Xiao Li, S., Wen, A. D., "Determination of venlafaxine in human plasma by high-performance liquid chromatography using could-point extraction and spectrofluorimetric detection" J. Chromatogr. B, 872, 38-42, 2008.
9. Juan, H., Zhiling, Z., Huande, L., "Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI)" J. Chromatogr. B, 820(1), 33-39, 2005.
10. Suenaga, EM., Ifa, D.R., Cruz, A.C., Pereira, R., Abib, E., Tominga, M., Nakaie, C. R., "Automated determination of venlafaxine in human plasma by on-line SPE-LC-MS/MS. Application to a bioequivalence study" J. Sep. Sci., 32(4), 637-43, 2009.
11. Paraskevas, D., Verdoukas, A., Demetrius, G., "Development and validation of a flow-injection assay for dissolution studies of the anti-depressant drug venlafaxine" Anal. Sci., 21, 1515, 2005.